No trading action warranted. This is a standard annual meeting filing with no surprises, all votes passed overwhelmingly. Monitor for any future 8-Ks related to strategic or financial developments.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 12 $62.29entry
- T+1 · 6mo ago 0.00%α −0.54% · $62.29
- T+5 · 6mo ago −1.25%α −1.33% · $61.51
- T+20 · 5mo ago +2.36%α +4.09% · $63.76
- T+60 · 3mo ago +12.88%α +8.49% · $70.31
Price Chart
How similar events traded
Executive Summary
GE HealthCare filed an 8-K reporting the results of its May 7, 2026 annual shareholder meeting and two board committee appointments. All director nominees were elected, executive compensation was approved in an advisory vote, and Deloitte & Touche was ratified as auditor. Rodney F. Hochman was appointed independent lead director, and Anne T. Madden was appointed chair of the Nominating and Governance Committee. This is a routine governance filing with no material financial impact.
Key Facts
- Annual shareholder meeting held May 7, 2026; all eight director nominees elected with strong support (lowest 'for' votes: Kevin A. Lobo at 332,339,981).
- Advisory vote on executive compensation approved with 351,099,781 'for' votes (96.4% of votes cast excluding broker non-votes).
- Ratification of Deloitte & Touche LLP as independent auditor for FY2026 approved with 398,257,878 'for' votes.
- Board appointed Rodney F. Hochman as independent lead director and Anne T. Madden as chair of the Nominating and Governance Committee, effective May 7, 2026.
Financial Impact
No financial impact, routine governance and board committee appointments.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001932393-26-000034 |
| Document: 0001932393-26-000034-index-headers.html | 0001932393-26-000034 |
| Document: 0001932393-26-000034-index.html | 0001932393-26-000034 |
| Document: 0001932393-26-000034.txt | 0001932393-26-000034 |
Track record
13 reports on GEHC
2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +19.07% at T+20 after the Oct 19, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 5, 202611d ago 8-K Neutral 3/10 Entry $83.75 to $81.84 Now $82.96 −0.94% ▼ −2.28% −5.57% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $83.75 to $81.84 Now $82.96 −0.94% ▼ −2.28% −5.57% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $75.82 to $85.81 Now $82.96 +9.42% ▲ +13.18% +13.89% vs SPY
- Oct 19, 202628d ago Institutional Cluster Bullish 4/10 Entry $69.72 to $71.60 Now $82.96 +18.99% ▲ +2.70% +2.84% vs SPY
- Sep 22, 20267w ago 8-K Neutral 2/10 Entry $66.09 to $65.37 Now $82.96 +25.53% ▼ −1.09% −0.41% vs SPY
- Sep 16, 20268w ago 3 Neutral 2/10 Entry $64.45 to $66.38 Now $82.96 +28.73% ▲ +3.00% +2.40% vs SPY
- Jul 29, 202615w ago 8-K Neutral 2/10 Entry $71.90 to $70.24 Now $82.96 +15.38% ▼ −2.31% −7.84% vs SPY
- May 13, 202626w ago Insider Cluster Neutral 2/10 Entry $64.26 to $62.86 Now $82.96 +29.10% ▼ −2.18% −3.98% vs SPY
- May 11, 202627w ago 8-K Neutral 2/10 Viewing Entry $62.29 to $61.51 Now $82.96 +33.18% ▼ −1.25% −1.33% vs SPY
- Apr 30, 202628w ago Insider Cluster Neutral 4/10 Entry $60.96 to $63.40 Now $82.96 +36.09% ▲ +4.00% +1.64% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers